LB
16
9
MAC
53
5
PSA
43
6
GM
55
6
CHD
34
7
NWSA
69
4
ALL
37
3
MSFT
55
2
INTU
54
2
SYF
78
7
HIG
48
5
SCHW
40
3
MCD
52
3
TGT
35
4
GT
43
2
SPG
45
2
SRE
37
9
LMT
29
-5
PPL
44
9
CNP
59
17
LB
16
9
MAC
53
5
PSA
43
6
GM
55
6
CHD
34
7
NWSA
69
4
ALL
37
3
MSFT
55
2
INTU
54
2
SYF
78
7
HIG
48
5
SCHW
40
3
MCD
52
3
TGT
35
4
GT
43
2
SPG
45
2
SRE
37
9
LMT
29
-5
PPL
44
9
CNP
59
17
Financhill
Back

10x Genomics 10K Form

Sell
34

TXG
10x Genomics

Last Price:
$14.74
Seasonality Move:
-7.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TXG News And Ratings

See the #1 stock for the next 7 days that we like better than TXG

TXG Financial Statistics

Sales & Book Value

Annual Sales: $618.7M
Cash Flow: $17.8M
Price / Cash Flow: 67.1
Annual Sales: $5.97
Price / Book: 2.35

Profitability

EPS (TTM): -1.53000
Net Income (TTM): $-182.6M
Gross Margin: $409.3M
Return on Equity: -24.99%
Return on Assets: -19.4%

10x Genomics Earnings Forecast

Key 10x Genomics Financial Ratios

  • The Gross Profit Margin over the past 7 years for TXG is 66.15%.
  • The Selling, General & Administrative Expenses for TXG have been equal to 55.49% of Gross Profit Margin.
  • The Research & Development expenses have been 43.69% of Revenue.
  • The Interest Expense is -0.01% of Operating Income.
  • The Net Earning history of TXG is -41.23% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

10x Genomics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: TXG
CUSIP: 88025U
Website: 10xgenomics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.9
Quick Ratio: 3.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TXG Technical Analysis vs Fundamental Analysis

Sell
34
10x Genomics (TXG) is a Sell

Is 10x Genomics a Buy or a Sell?

  • 10x Genomics stock is rated a Sell
    The current 10x Genomics [TXG] share price is $14.04. The Score for TXG is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.